2023
DOI: 10.18632/aging.204723
|View full text |Cite
|
Sign up to set email alerts
|

Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma

Abstract: Lipid remodeling regulators are now being investigated as potential therapeutic targets for cancer therapy as a result of their involvement, which includes promoting cancer cells’ adaptation to the restricted environment. Lysophosphatidylcholine acyltransferases (LPCATs, LPCAT1-4) are enzymes that regulate the remodeling of bio-membranes. The functions of these enzymes in cancer are largely unknown. In the current study, we found that genes belonging to the LPCAT family participated in tumor advancement and we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…Its increased expression in hepatocellular carcinoma is associated with a worse prognosis, suggesting a potential role as a therapeutic target for this cancer [ 18 , 133 ]. LPCAT4 is also implicated in cancer, with its expression decreased in colorectal cancer, suggesting an anticancer nature [ 74 ].…”
Section: 1-acylglycerol-3-phosphate O-acyltransferases and Lysophosph...mentioning
confidence: 99%
“…Its increased expression in hepatocellular carcinoma is associated with a worse prognosis, suggesting a potential role as a therapeutic target for this cancer [ 18 , 133 ]. LPCAT4 is also implicated in cancer, with its expression decreased in colorectal cancer, suggesting an anticancer nature [ 74 ].…”
Section: 1-acylglycerol-3-phosphate O-acyltransferases and Lysophosph...mentioning
confidence: 99%